Insider Transactions in Q3 2025 at Dexcom Inc (DXCM)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 05
2025
|
Kyle Malady Director |
SELL
Open market or private sale
|
Direct |
667
-2.86%
|
$53,360
$80.86 P/Share
|
|
Sep 04
2025
|
Sadie Stern EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
1,466
-1.37%
|
$117,280
$80.0 P/Share
|
|
Sep 02
2025
|
Jereme M Sylvain EVP, Chief Financal Officer |
SELL
Open market or private sale
|
Direct |
4,824
-3.91%
|
$356,976
$74.17 P/Share
|
|
Aug 15
2025
|
Michael Jon Brown EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
500
-0.53%
|
$40,000
$80.29 P/Share
|
|
Aug 15
2025
|
Mark G Foletta Director |
SELL
Open market or private sale
|
Indirect |
2,750
-2.56%
|
$222,750
$81.28 P/Share
|
|
Jul 28
2025
|
Sadie Stern EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
1,466
-1.36%
|
$129,008
$88.99 P/Share
|
|
Jul 15
2025
|
Mark G Foletta Director |
SELL
Open market or private sale
|
Indirect |
2,750
-2.43%
|
$233,750
$85.6 P/Share
|
|
Jul 15
2025
|
Michael Jon Brown EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
500
-0.53%
|
$43,000
$86.03 P/Share
|